Hsu Wellington K, Virk Mandeep S, Feeley Brian T, Stout David B, Chatziioannou Arion F, Lieberman Jay R
Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
J Nucl Med. 2008 Mar;49(3):414-21. doi: 10.2967/jnumed.107.045666. Epub 2008 Feb 20.
The combination of small-animal PET/CT scans and conventional imaging methods may enhance the evaluation of in vivo biologic interactions of murine models in the study of prostate cancer metastasis to bone.
Small-animal PET/CT scans using (18)F-fluoride ion and (18)F-FDG coregistered with high-resolution small-animal CT scans were used to longitudinally assess the formation of osteoblastic, osteolytic, and mixed lesions formed by human prostate cancer cell lines in a severe combined immunodeficient (SCID) mouse tibial injection model. These scans were correlated with plain radiographs, histomorphometry, and soft-tissue measurements.
Small-animal PET/CT scans were able to detect biologic activity of cells that induced an osteoblastic lesion 2 wk earlier than on plain radiographs. Furthermore, both the size and the activity of the lesions detected on PET/CT images significantly increased at each successive time point (P < 0.05). (18)F-FDG lesions strongly correlated with soft-tissue measurements, whereas (18)F-fluoride ion activity correlated with bone volume measured on histomorphometric analysis (P < 0.005). Osteolytic lesions were successfully quantified using small-animal CT, whereas lesion sizes measured on (18)F-FDG PET scans also strongly correlated with soft-tissue tumor burden (P < 0.05). In contrast, for mixed lesions, (18)F-fluoride ion and (18)F-FDG PET/CT scans detected only minimal activity.
(18)F-FDG and (18)F-fluoride ion PET/CT scans can be useful tools in characterizing pure osteolytic and osteoblastic lesions induced by human prostate cancer cell lines. The value of this technology needs further evaluation to determine whether these studies can be used effectively to detect more subtle responses to different treatment regimens in animal models.
在前列腺癌骨转移研究中,小动物PET/CT扫描与传统成像方法相结合,可能会增强对小鼠模型体内生物学相互作用的评估。
使用(18)F - 氟离子和(18)F - FDG进行小动物PET/CT扫描,并与高分辨率小动物CT扫描进行配准,以纵向评估人前列腺癌细胞系在严重联合免疫缺陷(SCID)小鼠胫骨注射模型中形成的成骨、溶骨和混合性病变的形成情况。这些扫描结果与X线平片、组织形态计量学和软组织测量结果相关联。
小动物PET/CT扫描能够比X线平片提前2周检测到诱导成骨病变的细胞的生物学活性。此外,在PET/CT图像上检测到的病变大小和活性在每个连续时间点均显著增加(P < 0.05)。(18)F - FDG病变与软组织测量结果密切相关,而(18)F - 氟离子活性与组织形态计量分析中测量的骨体积相关(P < 0.005)。溶骨病变通过小动物CT成功量化,而在(18)F - FDG PET扫描上测量的病变大小也与软组织肿瘤负荷密切相关(P < 0.05)。相比之下,对于混合性病变,(18)F - 氟离子和(18)F - FDG PET/CT扫描仅检测到最小活性。
(18)F - FDG和(18)F - 氟离子PET/CT扫描可作为表征人前列腺癌细胞系诱导的纯溶骨和成骨病变的有用工具。该技术的价值需要进一步评估,以确定这些研究是否能有效地用于检测动物模型中对不同治疗方案的更细微反应。